|
The Pharma Letter is an English pharmaceutical, generics and biotechnology news and analysis service. Coverage includes: * Company news. Financial reports, marketing developments, trends and strategies, corporate development, company profiles, legal influences, Research and Development trends, mergers and acquisitions activity, sales performance, stock market analyses and personnel appointments. * Product news. Drug submissions, approvals and rejections, licensing arrangements, clinical trial developments and results, product development and new product introductions. * European, USA and World news. Regulatory developments, FDA/EMEA news, market legislation, pharma market movements, reviews of current and proposed legislation and regulation, conference details and write-ups. Barbara Obstoj is the Managing Editor of The Pharma Letter, which in 2009 acquired the archives of The Pharma Marketletter, a publication that Barbara owned since 1991 and prior to that edited when it was part of IMS Health. Barbara was also the founding editor of Scrip World Pharmaceutical News (1972–1976) 抄文引用元・出典: フリー百科事典『 ウィキペディア（Wikipedia）』 ■ウィキペディアで「The Pharma Letter」の詳細全文を読む スポンサード リンク
|